Solu Therapeutics

Developer of therapeutics for oncology and immunology diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2022 groups9 employees language solutherapeutics.com

Social engagement

Social engagement: 4.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Longwood Fund, Sante.

Investor typeCountShare
Venture capital764%
Other / undisclosed436%

Recent activity

22 Jun 2026
Milestone
regulatory
18 Jun 2026
Event
Biotechnology Innovation Organization International Convention
10 Jun 2026
Event
European Hematology Association (EHA) 2026 Congress
Coming soon